Ειδήσεις: BIOTECH INVESTMENT | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

18/03 16:13 yahoo.com

Why Ionis Pharmaceuticals’ (IONS) 2026 Catalyst Pipeline Supported Leerink’s Higher Target

Ionis Pharmaceuticals Catalyst pipeline Leerink 2026 outlook RNA therapeutics revenue growth

17/03 16:05 yahoo.com

Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now?

Crispr Therapeutics gene editing stock analysis biotech investment CRISPR valuation

17/03 09:29 defenseworld.net

Boothbay Fund Management LLC Purchases 42,687 Shares of Avidity Biosciences, Inc. $RNA

Avidity Biosciences Boothbay Fund AlphaQuest biotech investment share purchase Q3 holdings

15/03 21:59 yahoo.com

A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?

hedge fund Immunovant biotech investment stock purchase healthcare sector market confidence

15/03 09:31 defenseworld.net

LENZ Therapeutics, Inc. $LENZ is Ally Bridge Group NY LLC’s 7th Largest Position

LENZ Therapeutics Ally Bridge Group institutional selling Q3 13F filing biotech investment portfolio weight

14/03 09:07 defenseworld.net

2,849,402 Shares in Whitehawk Therapeutics, Inc. $WHWK Purchased by Avoro Capital Advisors LLC

Avoro Capital Whitehawk Therapeutics Ocular Therapeutix institutional holdings 13F filing biotech investments

14/03 09:07 defenseworld.net

2,849,402 Shares in Whitehawk Therapeutics, Inc. $WHWK Purchased by Avoro Capital Advisors LLC

Avoro Capital Whitehawk Therapeutics Ocular Therapeutix institutional holdings 13F filing biotech investments

Loading...